Oncology & Cancer

Immunotherapy drug bolsters head and neck cancer treatment

A University of Cincinnati clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.

Oncology & Cancer

Advanced prostate cancer antibody drug shows success in pet dogs

Dogs are proving to be a far better scientific model for study of prostate cancer than mice, the typical animal used in the lab for this type of research. In the first use of canines in an advanced prostate cancer study, ...

Genetics

New genetic clues for multiple sclerosis risk

An international team of researchers led by Karolinska Institutet in Sweden reports that cells in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) ...

page 38 from 40